Processing

Please wait...

Settings

Settings

Goto Application

1. WO2018102162 - METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS

AU2017366813Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients
Appl.Date 17.11.2017
Appl.No 2017366813 Applicant Exosome Diagnostics, Inc. Pub.Kind A,A1
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 07.06.2018
EP3548635METHODS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS
Appl.Date 17.11.2017
Appl.No 17817952 Applicant EXOSOME DIAGNOSTICS INC Pub.Kind A1,B1 Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 09.10.2019
CN110446790METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS
Appl.Date 17.11.2017
Appl.No 201780084970.6 Applicant EXOSOME DIAGNOSTICS INC Pub.Kind A
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 12.11.2019
US20190376128METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS
Appl.Date 17.11.2017
Appl.No 16463820 Applicant Exosome Diagnostics, Inc. Pub.Kind A1
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 12.12.2019
JP2019536456非小細胞肺癌患者由来のエクソソームRNA及び無細胞DNAを使用して血漿中の変異を検出するための方法と組成物
Appl.Date 17.11.2017
Appl.No 2019528833 Applicant エクソサム ダイアグノスティクス,インコーポレイティド Pub.Kind A Pub.Lang ja
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 19.12.2019
WO/2018/102162METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS
Appl.Date 17.11.2017
Appl.No PCT/US2017/062370 Applicant EXOSOME DIAGNOSTICS, INC. Pub.Kind A Pub.Lang en
Inclusion Criteria IC1
PCT application from which the family originated.
Pub.Date 07.06.2018
CA3044056METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS
Appl.Date 15.05.2019
Appl.No 3044056 Applicant EXOSOME DIAGNOSTICS, INC. Pub.Kind A1 Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 07.06.2018